Last reviewed · How we verify
Standard bolus of insulin then extended bolus of insulin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Standard bolus of insulin then extended bolus of insulin (Standard bolus of insulin then extended bolus of insulin) — University of California, San Francisco.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Standard bolus of insulin then extended bolus of insulin TARGET | Standard bolus of insulin then extended bolus of insulin | University of California, San Francisco | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Standard bolus of insulin then extended bolus of insulin CI watch — RSS
- Standard bolus of insulin then extended bolus of insulin CI watch — Atom
- Standard bolus of insulin then extended bolus of insulin CI watch — JSON
- Standard bolus of insulin then extended bolus of insulin alone — RSS
Cite this brief
Drug Landscape (2026). Standard bolus of insulin then extended bolus of insulin — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-bolus-of-insulin-then-extended-bolus-of-insulin. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab